| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 398.891 | 90 |
| GSM780708 | Untreated after 4 days (C2_1) | 389.554 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 436.604 | 91 |
| GSM780719 | Untreated after 4 days (C1_2) | 406.098 | 90 |
| GSM780720 | Untreated after 4 days (C2_2) | 426.426 | 90 |
| GSM780721 | Untreated after 4 days (C3_2) | 434.802 | 91 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 469.296 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 415.699 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 432.555 | 90 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 479.287 | 91 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 424.18 | 90 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 403.174 | 90 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 455.32 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 428.663 | 90 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 453.163 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 423.088 | 90 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 426.23 | 90 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 461.454 | 91 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 372.827 | 89 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 466.735 | 91 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 369.283 | 89 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 414.892 | 90 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 442.839 | 91 |